FDA Inspection 1165209 — Igor (NMI) Grosman, DO
The FDA completed an inspection of Igor (NMI) Grosman, DO on Mar 3, 2022 in Brooklyn, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 3, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Brooklyn, NY (United States)
Additional Details
Clinical Investigator (CI)